Exicure (XCUR) Expected to Post Quarterly Earnings on Thursday

Exicure (NASDAQ:XCUR) is anticipated to issue its resultson Thursday, November 12th. Analysts expect the company to post earnings of ($18.60) per share and revenue of $1.64 million for the quarter.

Exicure (NASDAQ:XCUR) last issued its earnings results on Friday, August 14th. The company reported ($0.18) EPS for the quarter, beating the consensus estimate of ($18.60) by $18.42.

Exicure Price Performance

XCUR stock opened at $0.89 on Tuesday. The business’s fifty day moving average is $1.15 and its 200-day moving average is $2.59. Exicure has a twelve month low of $0.86 and a twelve month high of $9.48.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Exicure in a research note on Tuesday, September 8th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Exicure has an average rating of “Sell”.

About Exicure

Exicure, Inc is a biotechnology company that historically focused on developing therapeutics based on spherical nucleic acid (SNA) technology. The company’s platform was designed to use three-dimensional arrangements of nucleic acids to target specific genetic and biological pathways, with potential applications in diseases that are difficult to address using conventional drug-delivery approaches.

Exicure’s development programs included candidates for genetic and neurological disorders, as well as dermatological and other conditions.